Anthony D. Squeglia, PKE MBA ‘01

Anthony has been appointed CFO ofAnthony Squeglia Boston Therapeutics, a pharmaceutical company focused on the treatment of diabetes. He previously served as CFO of Pro-Pharmaceuticals and its successor company Galectin Therapeutics. Prior to that, Anthony was Pro-Pharmaceuticals’ vice president of investor relations. His career includes executive management positions at Summa Four, Unisys, AT&T, Timeplex, Colonial Penn and ITT.

Anthony D. Squeglia, PKE MBA ‘01

Read About These Alumni:

Tagged on:         

Leave a Reply